IMMUNOCELLULAR THERAPEUTICS

immunocellular-therapeutics-logo

ImmunoCellular Therapeuti is a clinical-stage biotechnology company. It is engaged in developing immune-based therapies for the treatment of cancers which can elicit an immune response against several antigens. The company has developed ICT-107, which is a dendritic cell (DC) immunotherapy for the treatment of newly diagnosed glioblastoma multiforme (GBM), which is a lethal type of brain cancer. It develops Immunotherapies for treating cancer in which a patient's own immune system is stimulated to target tumor antigens, which are molecular signals that the immune system uses to identify foreign bodies.

#SimilarOrganizations #People #Financial #Website #More

IMMUNOCELLULAR THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics Medical Device

Founded:
2006-01-01

Address:
Calabasas, California, United States

Country:
United States

Website Url:
http://www.imuc.com

Total Employee:
11+

Status:
Active

Contact:
(818) 264-2300

Email Addresses:
[email protected]

Total Funding:
32.47 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online IPv6


Similar Organizations

injectsense-logo

Injectsense

Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.

somalogic-logo

SomaLogic

SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.

Current Employees Featured

david-fractor_image

David Fractor
David Fractor CFO @ ImmunoCellular Therapeutics
CFO
2011-03-01

anthony-gringeri_image

Anthony Gringeri
Anthony Gringeri President, CEO, and Director @ ImmunoCellular Therapeutics
President, CEO, and Director

not_available_image

James G. Bender
James G. Bender Vice President @ ImmunoCellular Therapeutics
Vice President

john-s-yu_image

John S. Yu
John S. Yu Founder, Chief Scientific Officer, And Chairman @ ImmunoCellular Therapeutics
Founder, Chief Scientific Officer, And Chairman

Founder


john-s-yu_image

John S. Yu

Stock Details


Company's stock symbol is NYSEMKT:IMUC

Investors List

california-institute-for-regenerative-medicine_image

California Institute for Regenerative Medicine

California Institute for Regenerative Medicine investment in Grant - ImmunoCellular Therapeutics

asset-management-ventures_image

Asset Management Ventures (AMV)

Asset Management Ventures (AMV) investment in Venture Round - ImmunoCellular Therapeutics

Official Site Inspections

http://www.imuc.com Semrush global rank: 5.88 M Semrush visits lastest month: 1.41 K

  • Host name: 147.62.236.23.bc.googleusercontent.com
  • IP address: 23.236.62.147
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "ImmunoCellular Therapeutics" on Search Engine